Literature DB >> 24894116

Oxidized DJ-1 as a possible biomarker of Parkinson's disease.

Yoshiro Saito1.   

Abstract

Parkinson's disease is a progressive, age-related, neurodegenerative disorder, and oxidative stress is an important mediator in its pathogenesis. DJ-1 is a causative gene of a familial form of Parkinson's disease, namely PARK7, and plays a significant role in antioxidative defense to protect the cells from oxidative stress. DJ-1 undergoes preferential oxidation at the cysteine residue at position 106, Cys-106, under oxidative stress. The critical role of Cys-106 in the biological function of DJ-1 has been demonstrated, and recent studies indicate that DJ-1 acts as a sensor of oxidative stress by regulating the gene expression of antioxidative defense. Specific antibodies against Cys-106-oxidized DJ-1 have been developed, and the generation of oxidized DJ-1 in cellular and animal models of Parkinson's disease has been investigated. This review focuses on the role of DJ-1 in antioxidative defense and the importance of oxidizable Cys-106 in its function. The significance of the identification of early-phase Parkinson's disease biomarkers and the nature of oxidized DJ-1 as a biomarker for Parkinson's disease are discussed here.

Entities:  

Keywords:  DJ-1; Parkinson’s disease; cysteine; oxidative stress; sulfonic acid

Year:  2014        PMID: 24894116      PMCID: PMC4042152          DOI: 10.3164/jcbn.13-108

Source DB:  PubMed          Journal:  J Clin Biochem Nutr        ISSN: 0912-0009            Impact factor:   3.114


  71 in total

Review 1.  Autosomal recessive parkinsonism.

Authors:  Vincenzo Bonifati
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

2.  Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease.

Authors:  J Booij; G Tissingh; A Winogrodzka; G J Boer; J C Stoof; E C Wolters; E A van Royen
Journal:  Eur J Nucl Med       Date:  1997-01

3.  DJ-1, a novel regulator of the tumor suppressor PTEN.

Authors:  Raymond H Kim; Malte Peters; YingJu Jang; Wei Shi; Melania Pintilie; Graham C Fletcher; Carmela DeLuca; Jennifer Liepa; Lily Zhou; Bryan Snow; Richard C Binari; Armen S Manoukian; Mark R Bray; Fei-Fei Liu; Ming-Sound Tsao; Tak W Mak
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.

Authors:  S Orimo; E Ozawa; S Nakade; T Sugimoto; H Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

Review 6.  The Parkinson Progression Marker Initiative (PPMI).

Authors: 
Journal:  Prog Neurobiol       Date:  2011-09-14       Impact factor: 10.885

7.  Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells.

Authors:  Tomoya Kinumi; Junko Kimata; Takahiro Taira; Hiroyoshi Ariga; Etsuo Niki
Journal:  Biochem Biophys Res Commun       Date:  2004-05-07       Impact factor: 3.575

8.  Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1.

Authors:  Jens Waak; Stephanie S Weber; Karin Görner; Christoph Schall; Hidenori Ichijo; Thilo Stehle; Philipp J Kahle
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

9.  Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.

Authors:  Smitha Karunakaran; Latha Diwakar; Uzma Saeed; Varsha Agarwal; Sujanitha Ramakrishnan; Soumya Iyengar; Vijayalakshmi Ravindranath
Journal:  FASEB J       Date:  2007-03-16       Impact factor: 5.191

10.  DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease.

Authors:  Xiangmin Lin; Travis J Cook; Cyrus P Zabetian; James B Leverenz; Elaine R Peskind; Shu-Ching Hu; Kevin C Cain; Catherine Pan; John Scott Edgar; David R Goodlett; Brad A Racette; Harvey Checkoway; Thomas J Montine; Min Shi; Jing Zhang
Journal:  Sci Rep       Date:  2012-12-11       Impact factor: 4.379

View more
  22 in total

1.  PARK7 modulates autophagic proteolysis through binding to the N-terminally arginylated form of the molecular chaperone HSPA5.

Authors:  Dae-Hee Lee; Daeho Kim; Sung Tae Kim; Soyeon Jeong; Jung Lim Kim; Sang Mi Shim; Ah Jung Heo; Xinxin Song; Zong Sheng Guo; David L Bartlett; Sang Cheul Oh; Junho Lee; Yoshiro Saito; Bo Yeon Kim; Yong Tae Kwon; Yong J Lee
Journal:  Autophagy       Date:  2018-07-23       Impact factor: 16.016

Review 2.  Biomarkers for Parkinson's Disease: Recent Advancement.

Authors:  Sharvari Lotankar; Kedar S Prabhavalkar; Lokesh K Bhatt
Journal:  Neurosci Bull       Date:  2017-09-21       Impact factor: 5.203

3.  Stepwise oxidations play key roles in the structural and functional regulations of DJ-1.

Authors:  In-Kang Song; Mi-Sun Kim; James E Ferrell; Dong-Hae Shin; Kong-Joo Lee
Journal:  Biochem J       Date:  2021-10-15       Impact factor: 3.766

Review 4.  Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.

Authors:  Julia Doroszkiewicz; Magdalena Groblewska; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

5.  IFN-β rescues neurodegeneration by regulating mitochondrial fission via STAT5, PGAM5, and Drp1.

Authors:  Emilie Tresse; Lluís Riera-Ponsati; Elham Jaberi; Wei Qi Guinevere Sew; Karsten Ruscher; Shohreh Issazadeh-Navikas
Journal:  EMBO J       Date:  2021-04-29       Impact factor: 14.012

6.  Increased DJ-1 in urine exosome of Korean males with Parkinson's disease.

Authors:  Dong Hwan Ho; Sanghak Yi; Hyemyung Seo; Ilhong Son; Wongi Seol
Journal:  Biomed Res Int       Date:  2014-11-13       Impact factor: 3.411

7.  Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson's disease patients.

Authors:  Yoshiro Saito; Yoko Akazawa-Ogawa; Akihiro Matsumura; Kazumasa Saigoh; Sayoko Itoh; Kenta Sutou; Mayuka Kobayashi; Yuichiro Mita; Mototada Shichiri; Shin Hisahara; Yasuo Hara; Harutoshi Fujimura; Hiroyuki Takamatsu; Yoshihisa Hagihara; Yasukazu Yoshida; Takao Hamakubo; Susumu Kusunoki; Shun Shimohama; Noriko Noguchi
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

8.  Novel Redox-Dependent Esterase Activity (EC 3.1.1.2) for DJ-1: Implications for Parkinson's Disease.

Authors:  Emmanuel Vázquez-Mayorga; Ángel G Díaz-Sánchez; Ruben K Dagda; Carlos A Domínguez-Solís; Raul Y Dagda; Cynthia K Coronado-Ramírez; Alejandro Martínez-Martínez
Journal:  Int J Mol Sci       Date:  2016-08-22       Impact factor: 5.923

9.  Disruption of the Circadian Clock Alters Antioxidative Defense via the SIRT1-BMAL1 Pathway in 6-OHDA-Induced Models of Parkinson's Disease.

Authors:  Yali Wang; Dongjun Lv; Wenwen Liu; Siyue Li; Jing Chen; Yun Shen; Fen Wang; Li-Fang Hu; Chun-Feng Liu
Journal:  Oxid Med Cell Longev       Date:  2018-04-18       Impact factor: 6.543

Review 10.  Protein Glutathionylation in the Pathogenesis of Neurodegenerative Diseases.

Authors:  Sun Joo Cha; Hayoung Kim; Hyun-Jun Choi; Sanghyun Lee; Kiyoung Kim
Journal:  Oxid Med Cell Longev       Date:  2017-12-31       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.